Dolph Lundgren is opening up about his ongoing battle with cancer.
The ‘Rocky’ actor revealed he was told he only had ‘two or three years’ to live after his kidney cancer spread in the fall of 2021. Lundgren was in London at the time to begin production on “Aquaman and the Lost Kingdom” and “The Consumables 4.”
More from IndieWire
“We realized it was a lot worse than we thought,” Lundgren said during the latest “In Depth with Graham Bensinger” interview (below). “[The doctor] I kind of started talking about all these different tumors, like in the lungs, stomach, and spine, apart from the kidneys. He started saying these things like, “You should probably take a break and spend more time with your family”, etc.
Lundgren continued: “I asked him, ‘How much time do you think I have left?’ I think he said two or three years, but I could tell in his voice that he probably thought it was less.
The actor’s cancer was first discovered in 2015 when a tumor was removed.
“Then I did scans every six months, then you do every year and it was fine, you know, for five years,” Lundgren said. “In 2020 I was back in Sweden and I had some sort of acid reflux or…I didn’t know what it was. So I did an MRI and they found out there was a few other tumors in the area.
Six more tumors were discovered by doctors, leading Lundgren to begin systemic therapy and treatment that mirrored the way lung cancer is treated.
“If I had done the other treatment, I would have about three to four months left,” Lundgren said, citing that the lung cancer treatment had shrunk his tumors by about 30% in three months.
“2022 was basically watching these drugs do their job,” Lundgren summed up. “Eventually things had gone down to about 90%. Now I am in the process of removing the remaining scar tissue from these tumors… The prognosis is that hopefully when they remove them there will be no cancerous activity and that the drugs I’m taking will suppress everything else.”
Best of IndieWire
Sign up for the Indiewire newsletter. For the latest news, follow us on Facebook, Twitter and Instagram.
Click here to read the full article.
